NO20044092L - Oftalmisk sammensetning som innbefatter ascomycin - Google Patents

Oftalmisk sammensetning som innbefatter ascomycin

Info

Publication number: NO20044092L
Authority: NO; Norway
Prior art keywords: ascomycin; composition including; ophthalmic composition; ophthalmic; including ascomycin
Prior art date: 2002-03-04

Application number

NO20044092A

Other languages

English (en)

Norwegian (no)

Inventor

Shau-Fong Yen

Michelle Pik-Han Wong

Maggy Babiole Saunier

Jean-Claude Bizec

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-04

Filing date

2004-09-27

Publication date

2004-09-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044092(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-09-27 Application filed by Novartis Ag filed Critical Novartis Ag

2004-09-27 Publication of NO20044092L publication Critical patent/NO20044092L/no

Links

ZDQSOHOQTUFQEM-PKUCKEGBSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-PKUCKEGBSA-N 0.000 title 1
ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Oncology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO20044092A 2002-03-04 2004-09-27 Oftalmisk sammensetning som innbefatter ascomycin NO20044092L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US36151502P	2002-03-04	2002-03-04
US40927502P	2002-09-09	2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en)	2002-03-04	2003-03-03	Ophthalmic composition comprising ascomycin

Publications (1)

Publication Number	Publication Date
NO20044092L true NO20044092L (no)	2004-09-27

Family

ID=27791682

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044092A NO20044092L (no)	2002-03-04	2004-09-27	Oftalmisk sammensetning som innbefatter ascomycin

Country Status (27)

Country	Link
US (4)	US20050220823A1 (pl)
EP (1)	EP1482936B1 (pl)
JP (1)	JP4740542B2 (pl)
KR (1)	KR100992948B1 (pl)
CN (1)	CN1297270C (pl)
AR (1)	AR038628A1 (pl)
AT (1)	ATE341326T1 (pl)
AU (1)	AU2003218679B2 (pl)
BR (1)	BR0308184A (pl)
CA (1)	CA2477769C (pl)
CO (1)	CO5611133A2 (pl)
DE (1)	DE60308836T2 (pl)
DK (1)	DK1482936T3 (pl)
EC (1)	ECSP045277A (pl)
EG (1)	EG24403A (pl)
ES (1)	ES2274214T3 (pl)
IL (2)	IL163657A0 (pl)
MX (1)	MXPA04008571A (pl)
MY (1)	MY137563A (pl)
NO (1)	NO20044092L (pl)
NZ (1)	NZ534690A (pl)
PE (1)	PE20030828A1 (pl)
PL (1)	PL210870B1 (pl)
PT (1)	PT1482936E (pl)
RU (1)	RU2322982C2 (pl)
TW (1)	TW200305437A (pl)
WO (1)	WO2003074054A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004006890A1 (en)	2002-07-15	2004-01-22	Alcon, Inc.	Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
WO2004009056A1 (en) *	2002-07-23	2004-01-29	Novartis Ag	Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
GB0307866D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
BRPI0705564B8 (pt) *	2007-10-10	2021-05-25	Embrapa Pesquisa Agropecuaria	sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en)	2009-04-09	2010-10-13	Nestec S.A.	Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) *	2009-04-30	2014-05-20	Abbvie Inc.	Stabilized lipid formulation of apoptosis promoter
WO2010130428A1 (en) *	2009-05-12	2010-11-18	Galenica Ab	Oil-in-water emulsion of mometasone and propylene glycol
EP2515883A4 (en) *	2009-12-22	2013-07-17	Abbvie Inc	CAPSULE OF ABT-263
RU2437647C2 (ru) *	2010-02-27	2011-12-27	Пшеничников Виталий Георгиевич	Фармацевтическая композиция, обладающая антибактериальным, противовирусным и противогрибковым действием
CN102883708A (zh) *	2010-04-07	2013-01-16	阿勒根公司	用于眼用组合物的防腐剂联合
EP2664329A1 (de) *	2012-05-15	2013-11-20	F. Holzer GmbH	Ophthalmologisches Vehikelsystem
AU2013384818A1 (en) *	2013-03-27	2015-11-12	Comprehensive Drug Enterprises, Ltd.	Ophthalmic composition, method for preparing the same, and use of the same
US11103464B2 (en) *	2013-11-29	2021-08-31	Rohto Pharmaceutical Co., Ltd.	Aqueous composition for ophthalmological use or otolaryngological use
US11324800B2 (en)	2015-01-15	2022-05-10	Wellspring Ophthalmics, Inc.	Aqueous suspensions of cyclosporin
US20200237859A1 (en)	2019-01-25	2020-07-30	Newport Research, Inc.	Aqueous suspensions of cyclosporin
US10606760B2 (en) *	2017-08-23	2020-03-31	Samsung Electronics Co., Ltd.	Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en)	2019-05-21	2020-11-25	Premark Pharma GmbH	Treatment of ocular disease
TW202432089A (zh) *	2023-01-31	2024-08-16	溫士頓醫藥股份有限公司	一種滴眼油劑型的醫藥組合物
EP4687895A1 (en)	2023-04-06	2026-02-11	Premark Pharma GmbH	Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE66485B1 (en) *	1989-07-05	1996-01-10	Fujisawa Pharmaceutical Co	Aqueous liquid composition for external use
ES2099112T3 (es) *	1990-09-04	1997-05-16	Fujisawa Pharmaceutical Co	Pomadas que contienen un compuesto triciclico.
PH31204A (en) *	1990-11-02	1998-05-05	Fujisawa Pharmaceutical Co	Pharmaceutical composition.
IE65341B1 (en) *	1990-11-08	1995-10-18	Fujisawa Pharmaceutical Co	Suspensions containing tricyclic compounds
CA2142103C (en) *	1992-08-28	2003-07-08	Haim Aviv	Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) *	1993-06-08	1994-12-20	Fujisawa Pharmaceut Co Ltd	ローション剤
JPH08502759A (ja) *	1993-08-18	1996-03-26	アルコンラボラトリーズ，インコーポレイテッド	緑内障治療用のエルゴリン誘導体の使用
WO1996011003A1 (en) *	1994-10-10	1996-04-18	Novartis Ag	Ophthalmic and aural compositions containing diclofenac potassium
NZ331824A (en) *	1994-10-26	2000-01-28	Novartis Ag	use of an unsaturated fatty alcohol to stabilise a macrolide in a pharmaceutical composition
EP0737471A3 (fr) *	1995-04-10	2000-12-06	L'oreal	Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732598B1 (fr) *	1995-04-10	1997-05-09	Oreal	Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US6096785A (en) *	1996-07-30	2000-08-01	Novartis Nutrition Ag	Amino acid compositions and use thereof in treating renal dysfunction
FR2755852B1 (fr) *	1996-11-15	1998-12-24	Oreal	Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
WO1999055332A1 (en) *	1998-04-27	1999-11-04	Fujisawa Pharmaceutical Co., Ltd.	Medicinal compositions
GB9826656D0 (en) *	1998-12-03	1999-01-27	Novartis Ag	Organic compounds
CN1190194C (zh) *	1999-04-30	2005-02-23	苏坎波公司	用于治疗干眼的大环内酯化合物的应用

2003
- 2003-02-28 PE PE2003000198A patent/PE20030828A1/es not_active Application Discontinuation
- 2003-02-28 AR ARP030100667A patent/AR038628A1/es unknown
- 2003-03-02 EG EG2003030208A patent/EG24403A/xx active
- 2003-03-03 PT PT03711914T patent/PT1482936E/pt unknown
- 2003-03-03 CA CA2477769A patent/CA2477769C/en not_active Expired - Fee Related
- 2003-03-03 BR BR0308184-2A patent/BR0308184A/pt not_active IP Right Cessation
- 2003-03-03 PL PL370917A patent/PL210870B1/pl not_active IP Right Cessation
- 2003-03-03 US US10/506,233 patent/US20050220823A1/en not_active Abandoned
- 2003-03-03 IL IL16365703A patent/IL163657A0/xx unknown
- 2003-03-03 WO PCT/EP2003/002156 patent/WO2003074054A1/en not_active Ceased
- 2003-03-03 AU AU2003218679A patent/AU2003218679B2/en not_active Ceased
- 2003-03-03 AT AT03711914T patent/ATE341326T1/de active
- 2003-03-03 TW TW092104405A patent/TW200305437A/zh unknown
- 2003-03-03 DE DE60308836T patent/DE60308836T2/de not_active Expired - Lifetime
- 2003-03-03 MX MXPA04008571A patent/MXPA04008571A/es active IP Right Grant
- 2003-03-03 MY MYPI20030758A patent/MY137563A/en unknown
- 2003-03-03 CN CNB038052105A patent/CN1297270C/zh not_active Expired - Fee Related
- 2003-03-03 DK DK03711914T patent/DK1482936T3/da active
- 2003-03-03 EP EP03711914A patent/EP1482936B1/en not_active Expired - Lifetime
- 2003-03-03 KR KR1020047013051A patent/KR100992948B1/ko not_active Expired - Fee Related
- 2003-03-03 ES ES03711914T patent/ES2274214T3/es not_active Expired - Lifetime
- 2003-03-03 RU RU2004129593/15A patent/RU2322982C2/ru not_active IP Right Cessation
- 2003-03-03 NZ NZ534690A patent/NZ534690A/en not_active IP Right Cessation
- 2003-03-03 JP JP2003572571A patent/JP4740542B2/ja not_active Expired - Fee Related
2004
- 2004-08-19 IL IL163657A patent/IL163657A/en not_active IP Right Cessation
- 2004-09-03 EC EC2004005277A patent/ECSP045277A/es unknown
- 2004-09-16 CO CO04092300A patent/CO5611133A2/es not_active Application Discontinuation
- 2004-09-27 NO NO20044092A patent/NO20044092L/no not_active Application Discontinuation
2009
- 2009-12-15 US US12/638,313 patent/US20100113501A1/en not_active Abandoned
2011
- 2011-03-01 US US13/037,399 patent/US20110152307A1/en not_active Abandoned
- 2011-09-23 US US13/241,340 patent/US20120015971A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2477769C (en)	2011-01-18
US20120015971A1 (en)	2012-01-19
ECSP045277A (es)	2004-10-26
DE60308836T2 (de)	2007-04-26
HK1071301A1 (en)	2005-07-15
ES2274214T3 (es)	2007-05-16
US20050220823A1 (en)	2005-10-06
RU2004129593A (ru)	2005-09-10
PT1482936E (pt)	2007-01-31
ATE341326T1 (de)	2006-10-15
MY137563A (en)	2009-02-27
PE20030828A1 (es)	2003-11-04
RU2322982C2 (ru)	2008-04-27
WO2003074054A1 (en)	2003-09-12
CO5611133A2 (es)	2006-02-28
IL163657A0 (en)	2005-12-18
EG24403A (en)	2009-04-29
MXPA04008571A (es)	2004-12-06
AU2003218679A1 (en)	2003-09-16
PL370917A1 (pl)	2005-06-13
BR0308184A (pt)	2005-01-11
TW200305437A (en)	2003-11-01
KR100992948B1 (ko)	2010-11-08
CN1297270C (zh)	2007-01-31
CN1638769A (zh)	2005-07-13
AR038628A1 (es)	2005-01-19
DK1482936T3 (da)	2007-01-08
EP1482936B1 (en)	2006-10-04
JP4740542B2 (ja)	2011-08-03
CA2477769A1 (en)	2003-09-12
AU2003218679B2 (en)	2007-04-05
NZ534690A (en)	2007-06-29
DE60308836D1 (de)	2006-11-16
EP1482936A1 (en)	2004-12-08
PL210870B1 (pl)	2012-03-30
US20110152307A1 (en)	2011-06-23
IL163657A (en)	2009-11-18
US20100113501A1 (en)	2010-05-06
JP2005529851A (ja)	2005-10-06
KR20040094718A (ko)	2004-11-10

Legal Events

Date	Code	Title	Description
2011-10-24	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20040775L (no)	2004-02-17	Oftalmisk sammensetning som innbefatter et askomycin
NO20044654L (no)	2004-10-28	Piperidinoylpiperidiner som 5-HTIF-agonister
PL373336A1 (pl)	2005-08-22	Pirazolopirydyny podstawione karbaminianem
DE60312054D1 (de)	2007-04-12	Prothese
DE602004031845D1 (de)	2011-04-28	Ng
NO20050426L (no)	2005-03-29	Arylkarbonylderivater som terapeutiske midler
DE10393374D2 (de)	2005-09-01	Zusammensetzung
EP1534786A4 (en)	2005-10-26	COLORING COMPOSITIONS
BRPI0313075A2 (pt)	2017-05-02	composições de vidro
DE60306259D1 (de)	2006-08-03	Auswuchtgerät
DK1482936T3 (da)	2007-01-08	Öjenpræparat omfattende ascomycin
DK1492934T3 (da)	2010-10-04	Dørenhed
DK1556377T3 (da)	2006-10-23	Cyclopropylthienylcarboxamider som fungicider
DE60322421D1 (de)	2008-09-04	Verbesserter brillenbügel
SE0500163L (sv)	2005-01-24	Sammansättning
DE60236403D1 (de)	2010-07-01	Tourbillonmechanismus
DE50307217D1 (de)	2007-06-21	Glaskörper
DE602004018799D1 (de)	2009-02-12	Ng
EP1487414A4 (en)	2007-12-12	ANTIBIOTIC COMPOSITION
NO20043664L (no)	2004-09-01	Ny fremgangsmate
EP1561467A4 (en)	2008-06-25	COMPOSITION FOR RECOVERING DAMAGED SKIN
DE60328488D1 (de)	2009-09-03	Ng
ITMI20031187A0 (it)	2003-06-12	Astuccio per occhiali
NO20044140D0 (no)	2004-09-29	New Composition
DE60333472D1 (de)	2010-09-02	Kautschukzusammensetzung